Update on the therapy of Behçet disease

Zeinab Saleh, Thurayya Arayssi

Research output: Contribution to journalReview article

51 Citations (Scopus)

Abstract

Behçet disease is a chronic inflammatory systemic disorder, characterized by a relapsing and remitting course. It manifests with oral and genital ulcerations, skin lesions, uveitis, and vascular, central nervous system and gastrointestinal involvement. The main histopathological finding is a widespread vasculitis of the arteries and veins of any size. The cause of this disease is presumed to be multifactorial involving infectious triggers, genetic predisposition, and dysregulation of the immune system. As the clinical expression of Behçet disease is heterogeneous, pharmacological therapy is variable and depends largely on the severity of the disease and organ involvement. Treatment of Behçet disease continues to be based largely on anecdotal case reports, case series, and a few randomized clinical trials.

Original languageEnglish
Pages (from-to)112-134
Number of pages23
JournalTherapeutic Advances in Chronic Disease
Volume5
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Therapeutics
Uveitis
Genetic Predisposition to Disease
Vasculitis
Blood Vessels
Veins
Immune System
Central Nervous System
Randomized Controlled Trials
Arteries
Pharmacology
Skin

Keywords

  • Behçet disease
  • Behçet syndrome
  • Biologic therapy
  • Therapy
  • Treatment
  • Tumor necrosis factor α

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Update on the therapy of Behçet disease. / Saleh, Zeinab; Arayssi, Thurayya.

In: Therapeutic Advances in Chronic Disease, Vol. 5, No. 3, 2014, p. 112-134.

Research output: Contribution to journalReview article

@article{5aeb0da20e7b4cef8edcfd6d4794e5df,
title = "Update on the therapy of Beh{\cc}et disease",
abstract = "Beh{\cc}et disease is a chronic inflammatory systemic disorder, characterized by a relapsing and remitting course. It manifests with oral and genital ulcerations, skin lesions, uveitis, and vascular, central nervous system and gastrointestinal involvement. The main histopathological finding is a widespread vasculitis of the arteries and veins of any size. The cause of this disease is presumed to be multifactorial involving infectious triggers, genetic predisposition, and dysregulation of the immune system. As the clinical expression of Beh{\cc}et disease is heterogeneous, pharmacological therapy is variable and depends largely on the severity of the disease and organ involvement. Treatment of Beh{\cc}et disease continues to be based largely on anecdotal case reports, case series, and a few randomized clinical trials.",
keywords = "Beh{\cc}et disease, Beh{\cc}et syndrome, Biologic therapy, Therapy, Treatment, Tumor necrosis factor α",
author = "Zeinab Saleh and Thurayya Arayssi",
year = "2014",
doi = "10.1177/2040622314523062",
language = "English",
volume = "5",
pages = "112--134",
journal = "Therapeutic Advances in Chronic Disease",
issn = "2040-6223",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Update on the therapy of Behçet disease

AU - Saleh, Zeinab

AU - Arayssi, Thurayya

PY - 2014

Y1 - 2014

N2 - Behçet disease is a chronic inflammatory systemic disorder, characterized by a relapsing and remitting course. It manifests with oral and genital ulcerations, skin lesions, uveitis, and vascular, central nervous system and gastrointestinal involvement. The main histopathological finding is a widespread vasculitis of the arteries and veins of any size. The cause of this disease is presumed to be multifactorial involving infectious triggers, genetic predisposition, and dysregulation of the immune system. As the clinical expression of Behçet disease is heterogeneous, pharmacological therapy is variable and depends largely on the severity of the disease and organ involvement. Treatment of Behçet disease continues to be based largely on anecdotal case reports, case series, and a few randomized clinical trials.

AB - Behçet disease is a chronic inflammatory systemic disorder, characterized by a relapsing and remitting course. It manifests with oral and genital ulcerations, skin lesions, uveitis, and vascular, central nervous system and gastrointestinal involvement. The main histopathological finding is a widespread vasculitis of the arteries and veins of any size. The cause of this disease is presumed to be multifactorial involving infectious triggers, genetic predisposition, and dysregulation of the immune system. As the clinical expression of Behçet disease is heterogeneous, pharmacological therapy is variable and depends largely on the severity of the disease and organ involvement. Treatment of Behçet disease continues to be based largely on anecdotal case reports, case series, and a few randomized clinical trials.

KW - Behçet disease

KW - Behçet syndrome

KW - Biologic therapy

KW - Therapy

KW - Treatment

KW - Tumor necrosis factor α

UR - http://www.scopus.com/inward/record.url?scp=84898958765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898958765&partnerID=8YFLogxK

U2 - 10.1177/2040622314523062

DO - 10.1177/2040622314523062

M3 - Review article

AN - SCOPUS:84898958765

VL - 5

SP - 112

EP - 134

JO - Therapeutic Advances in Chronic Disease

JF - Therapeutic Advances in Chronic Disease

SN - 2040-6223

IS - 3

ER -